PM
HAE icon

Prosight Management’s Haemonetics HAE Stock Holding History

Prosight Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-65,400
Closed -$4.16M – 43
2025
Q1 		$4.16M Buy
65,400
+18,700
+40% +$1.27M 1.37% 24
2024
Q4 		$3.65M Sell
46,700
-18,300
-28% -$1.47M 1.01% 24
2024
Q3 		$5.22M Buy
+65,000
New +$5.25M 1.29% 24
2021
Q4 		– Sell
-38,319
Closed -$2.71M – 42
2021
Q3 		$2.71M Sell
38,319
-95,681
-71% -$6.04M 1.49% 25
2021
Q2 		$8.93M Buy
+134,000
New +$9.48M 5.58% 4

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Prosight Management's HAE Position: Q2 2025 in Review

Prosight Management sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 65,400 shares — an estimated $4.16M sold.

Prosight Management first reported a position in HAE in Q2 2021 and held it in 5 quarters. The position peaked at $8.93M in Q2 2021. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Prosight Management reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Prosight Management sold 65,400 Haemonetics shares in Q2 2025, an estimated $4.16M.
  • Prosight Management first reported a position in Haemonetics in Q2 2021 and held it in 5 quarters.
  • Prosight Management's Haemonetics position peaked at $8.93M in Q2 2021.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Prosight Management's 13F filing for Q2 2025, filed 14 Aug 2025.